Arg64 variant of the β3-adrenergic receptor is associated with gallstone formation

American Journal of Gastroenterology

Volumn 102, Issue 11, 2007, Pages 2482-2487

  Klass, Dietmar M ^a   Lauer, Nadine ^a   Hay, Birgit ^b   Kratzer, Wolfgang ^a   Fuchs, Michael ^a,c   Adler, G ^d   Armsen, A ^d   Banzhaf, H M ^d   Bauerdick, M ^d   Bertling, U ^d   Boehm, B O ^d   Brandner, B O ^d   Brockmann, S O ^d   Deckert, M ^d   Dingler, C ^d   Eggink, S ^d   Fuchs, M ^d   Gaus, W ^d   Goussis, H ^d   Gruenert, A ^d   Haenle, M M ^d   Hampl, W ^d   Haug, C ^d   Hay, B ^d   Huetter, M L ^d   Imhof, A ^d   Kern, P ^d   Kimmig, P ^d   Kirch, A ^d   Klass, D ^d   Koenig, W ^d   Kratzer, W ^d   Kron, M ^d   Manfras, B ^d   Meitinger, K ^d   Mertens, T ^d   Oehme, R ^d   Pfaff, G ^d   Piechotowski, I ^d   Reuter, S ^d   Romig, T ^d   Von Schmiesing, A F A ^d   Steinbach, G ^d   Tourbier, M ^d   Voegtle, A ^d   Walcher, T ^d   Wolff, S ^d   more..

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Klinik für Innere Medizin I ^*

Author keywords

[No Author keywords available]

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; GENOMIC DNA; ARGININE; TRYPTOPHAN;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD SAMPLING; CHEMICAL ANALYSIS; CHOLECYSTOGRAPHY; CHRONIC DISEASE; CONTROLLED STUDY; DNA ISOLATION; ECHOGRAPHY; FEMALE; GALLSTONE FORMATION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GERMANY; HEALTH BEHAVIOR; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; OBESITY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RANDOMIZATION; RECEPTOR GENE; RISK ASSESSMENT; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; BODY MASS; CROSS-SECTIONAL STUDY; GALLSTONE; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; STATISTICAL MODEL;

ARGININE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GALLSTONES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERMANY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MUTATION, MISSENSE; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-3; TRYPTOPHAN;

EID: 35448945125     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01430.x     Document Type: Article

References (33)

1. Apstein MD, Carey MC. Pathogenesis of cholesterol gallstones: A parsimonious hypothesis. Eur J Clin Invest 1996 26 : 343 52.
2. Pauletzki J, Althaus R, Holl J, et al. Gallbladder emptying and gallstone formation: A prospective study on gallstone recurrence. Gastroenterology 1996 111 : 765 71.
3. Festi D, Frabboni R, Bazzoli F, et al. Gallbladder motility in cholesterol gallstone disease. Effect of ursodeocxcholic acid administration and gallstone dissolution. Gastroenterology 1990 99 : 1779 85.
4. Jazrawi RP, Pazzi P, Petroni ML, et al. Postprandial gallbladder motor function: Refilling and turnover of bile in health and in cholelithiasis. Gastroenterology 1995 109 : 582 91.
5. Klass DM, Bührmann K, Sauter G, et al. Biliary lipids, cholesterol and bile synthesis: Different adaptive mechanisms to dietary cholesterol in lean and obese subjects. Aliment Pharmacol Ther 2006 23 : 895 905.
6. Chen Q, Amaral J, Biancani P, et al. Excess membrane cholesterol alters human gallbladder muscle contractility and membrane fluidity. Gastroenterology 1999 116 : 678 85.
7. Yu P, Chen Q, Harnett KM, et al. Direct G protein activation reverses impaired CCK signaling in human gallbladders with cholesterol stones. Am J Physiol 1995 269 : G659 65.
8. Strosberg AD. Structure and function of the beta 3 adrenoreceptor. Adv Pharmacol 1998 42 : 511 3.
9. Anthony A, Schepelmann S, Guillaume JL, et al. Localization of the ß(beta)3-adrenoceptor in the human gastrointestinal tract: An immunohistochemical study. Aliment Pharmacol Ther 1998 12 : 519 25.
10. Oriowo MA, Thulesius O. Functional characterization of beta-adrenoceptors mediating relaxation in sheep gallbladder. Fundam Clin Pharmacol 1999 13 : 187 92.
11. Walston J, Silver K, Bogardus C, et al. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N Engl J Med 1995 333 : 343 7.
12. Zhan S, Ho SC. Meta-analysis of the association of the Trp64Arg polymorphism in the beta3 adrenergic receptor with insulin resistance. Obes Res 2005 13 : 1709 19.
13. Widen E, Lehto M, Kanninen T, et al. Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 1995 333 : 348 51.
14. Clement K, Vaisse C, Manning BS, et al. Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 1995 333 : 352 4.
15. Mitchell BD, Blangero J, Comuzzie AG, et al. A paired sibling analysis of the beta-3 adrenergic receptor and obesity in Mexican Americans. J Clin Invest 1998 101 : 584 7.
16. Endo K, Yanagi H, Hirano C, et al. Association of Trp64Arg polymorphism of the beta3-adrenergic receptor gene and no association of Gln223Arg polymorphism of the leptin receptor gene in Japanese schoolchildren with obesity. Int J Obes Relat Metab Disord 2000 24 : 443 9.
17. Ringel J, Kreutz R, Distler A, et al. The Trp64Arg polymorphism of the beta3-adrenergic receptor gene is associated with hypertension in men with type 2 diabetes mellitus. Am J Hypertens 2000 13 : 1027 31.
18. Thomas GN, Tomlinson B, Chan JC, et al. An insulin receptor gene polymorphism is associated with diastolic blood pressure in Chinese subjects with components of the metabolic syndrome. Am J Hypertens 2000 13 : 745 52.
19. Corella D, Guillen M, Portoles O, et al. Gender specific associations of the Trp64Arg mutation in the beta3-adrenergic receptor gene with obesity-related phenotypes in a Mediterranean population: Interaction with a common lipoprotein lipase gene variation. J Intern Med 2001 250 : 348 60.
20. Kawamura T, Egusa G, Fujikawa R, et al. Beta(3)-adrenergic receptor gene variant is associated with upper body obesity only in obese Japanese-American men but not in women. Diabetes Res Clin Pract 2001 54 : 49 55.
21. Hsueh WC, Cole SA, Shuldiner AR, et al. Interactions between variants in the beta3-adrenergic receptor and peroxisome proliferator-activated receptor-gamma2 genes and obesity. Diabetes Care 2001 24 : 672 7.
22. Kimura K, Sasaki N, Asano A, et al. Mutated human beta3-adrenergic receptor (Trp64Arg) lowers the response to beta3-adrenergic agonists in transfected 3T3-L1 preadipocytes. Horm Metab Res 2000 32 : 91 6.
23. Walcher T, Haenle MM, Kron M, et al. Pregnancy is not a risk factor for gallstone disease: Results of a randomly selected population sample. World J Gastroenterol 2005 11 : 6800 6.
24. Haenle MM, Brockmann SO, Kron M, et al. Overweight, physical activity, tobacco and alcohol consumption in a cross-sectional random sample of German adults. BMC Public Health 2006 6 : 233.
25. Juvonen T, Kervinen K, Kairaluoma MI, et al. Gallstone cholesterol content is related to apolipoprotein E polymorphism. Gastroenterology 1993 104 : 1806 13.
26. Scragg RK, Calvert GD, Oliver JR. Plasma lipids and insulin in gall stone disease: A case-control study. Br Med J 1984 289 : 521 5.
27. Attili AF, Capocaccia R, Carulli N, et al. Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis. Hepatology 1997 26 : 809 18.
28. Everhart JE, Khare M, Hill M, et al. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology 1999 117 : 632 9.
29. Nakeeb A, Comuzzie AG, Martin L, et al. Gallstones: Genetics versus environment. Ann Surg 2002 235 : 842 9.
30. Jiang ZY, Han TQ, Suo GJ, et al. Polymorphisms at cholesterol 7alpha-hydroxylase, apolipoproteins B and E and low density lipoprotein receptor genes in patients with gallbladder stone disease. World J Gastroenterol 2004 10 : 1508 12.
31. Dixit M, Choudhuri G, Keshri LJ, et al. Association of low density lipoprotein receptor related protein-associated protein (LRPAP1) gene insertion/deletion polymorphism with gallstone disease. J Gastroenterol Hepatol 2006 21 : 847 9.
32. Wang DQ, Schmitz F, Kopin AS, et al. Targeted disruption of the murine cholecystokinin-1 receptor promotes intestinal cholesterol absorption and susceptibility to cholesterol cholelithiasis. J Clin Invest 2004 114 : 521 8.
33. De Ponti F, Gibelli G, Crema F, et al. Functional evidence for the presence of beta 3-adrenoceptors in the guinea pig common bile duct and colon. Pharmacology 1995 51 : 288 97.